A Pilot Study on the Use of Prophylactic Antibiotics for EUS-guided Pancreatic Cyst Aspiration

NCT01929460 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2016-02-15

Study results available
· View outcomes & findings →

Summary

Our hypothesis is that a single dose of antibiotics at time of EUS-guided pancreatic cyst aspiration is equally effective to the usual regimen of 3 days of post-procedural antibiotics.

Conditions

  • Pancreatic Cysts

Interventions

DRUG

Ciprofloxacin

ciprofloxacin oral capsule (one capsule twice a day for 3 days)

OTHER

Placebo (for ciprofloxacin)

oral placebo capsule (one capsule twice a day for 3 days)

Sponsors & Collaborators

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Karl Kwok, MD · Principal Investigator

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01929460 on ClinicalTrials.gov